Cisplatin-E Therapeutic Implant

An injectable collagen matrix gel containing the inorganic platinum agent cisplatin and the sympathicomimetic agent epinephrine with potential antineoplastic activity. After intratumoral injection, cisplatin alkylates guanine nucleosides in DNA, and causes DNA-DNA or DNA-protein cross-linkages, thereby preventing DNA replication and resulting in tumor cell growth inhibition and apoptosis. Epinephrine, a potent vasoconstrictor, is added to the gel to enhance penetration of cisplatin into tumor tissue and reduce dispersion into the surrounding tissues. Intratumoral injection of cisplatin-E therapeutic implant may increase local chemotherapeutic efficacy compared to the systemic administration of these agents while reducing systemic toxicity. (NCI Thesaurus)

YOU MAY ALSO LIKE

Cisplatin-Doxorubicin-Paclitaxel Regimen

A regimen consisting of cisplatin, doxorubicin and paclitaxel used for the treatment of advanced stage or recurrent endometrial cancer.

Cisplatin-Doxorubicin-Methotrexate Regimen

A regimen consisting of cisplatin, doxorubicin, and methotrexate used as an adjuvant treatment for localized childhood osteosarcoma.

Cisplatin-Cetuximab Regimen

A chemoimmunotherapy regimen consisting of cisplatin and cetuximab used for the treatment of unresectable squamous cell head and neck cancer.

Cisplatin Liposomal

A synthetic formulation in which the antineoplastic agent cisplatin is encapsulated in lipids. Cisplatin liposomal consists of small aggregates of cisplatin…

Cisplatin

A drug used to treat malignant mesothelioma, non-small cell lung cancer, squamous cell carcinoma of the head and neck, and cancers of…

CISNET

A group of researchers supported by the National Cancer Institute (NCI) who use statistical models to help understand how cancer prevention, screening,…